APA (7th ed.) Citation

He, S., Niu, G., Shang, J., Deng, Y., Wan, Z., Zhang, C., . . . Shen, H. (2017). The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway. Journal of experimental & clinical cancer research, 36(1), 137-12. https://doi.org/10.1186/s13046-017-0607-0

Chicago Style (17th ed.) Citation

He, Shanyang, Gang Niu, Jianhong Shang, Yalan Deng, Zhiyong Wan, Cai Zhang, Zeshan You, and Hongwei Shen. "The Oncogenic Golgi Phosphoprotein 3 like Overexpression Is Associated with Cisplatin Resistance in Ovarian Carcinoma and Activating the NF-κB Signaling Pathway." Journal of Experimental & Clinical Cancer Research 36, no. 1 (2017): 137-12. https://doi.org/10.1186/s13046-017-0607-0.

MLA (9th ed.) Citation

He, Shanyang, et al. "The Oncogenic Golgi Phosphoprotein 3 like Overexpression Is Associated with Cisplatin Resistance in Ovarian Carcinoma and Activating the NF-κB Signaling Pathway." Journal of Experimental & Clinical Cancer Research, vol. 36, no. 1, 2017, pp. 137-12, https://doi.org/10.1186/s13046-017-0607-0.